BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1871 related articles for article (PubMed ID: 25788569)

  • 1. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
    Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial.
    Danhof NA; van Wely M; Repping S; Koks C; Verhoeve HR; de Bruin JP; Verberg MFG; van Hooff MHA; Cohlen BJ; van Heteren CF; Fleischer K; Gianotten J; van Disseldorp J; Visser J; Broekmans FJM; Mol BWJ; van der Veen F; Mochtar MH;
    Hum Reprod; 2018 Oct; 33(10):1866-1874. PubMed ID: 30137325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frozen-thawed embryo transfer in a natural or mildly hormonally stimulated cycle in women with regular ovulatory cycles: a RCT.
    Peeraer K; Couck I; Debrock S; De Neubourg D; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Meuleman C; D'Hooghe T
    Hum Reprod; 2015 Nov; 30(11):2552-62. PubMed ID: 26364081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
    Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
    Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
    Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
    van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M
    Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.
    Erdem M; Abay S; Erdem A; Firat Mutlu M; Nas E; Mutlu I; Oktem M
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of ovarian stimulation with gonadotrophin and clomiphene citrate in an intrauterine insemination programme for subfertile couples.
    Peeraer K; Luyten J; Tomassetti C; Verschueren S; Spiessens C; Tanghe A; Meuleman C; Debrock S; Dancet E; D'Hooghe T
    Reprod Biomed Online; 2018 Mar; 36(3):302-310. PubMed ID: 29395750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pregnancy rates with intrauterine insemination (IUI) in superovulated cycles employing different protocols (clomiphen citrate (CC), human menopausal gonadotropin (HMG) and HMG+CC) and in natural ovulatory cycle.
    Mahani IM; Afnan M
    J Pak Med Assoc; 2004 Oct; 54(10):503-5. PubMed ID: 15552282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.
    Bordewijk EM; Jannink TI; Weiss NS; de Vries T; Nahuis M; Hoek A; Goddijn M; Mol BW; van Wely M;
    Hum Reprod; 2023 Mar; 38(3):421-429. PubMed ID: 36622200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis.
    Wessel JA; Danhof NA; van Eekelen R; Diamond MP; Legro RS; Peeraer K; D'Hooghe TM; Erdem M; Dankert T; Cohlen BJ; Thyagaraju C; Mol BWJ; Showell M; van Wely M; Mochtar MH; Wang R
    Hum Reprod Update; 2022 Aug; 28(5):733-746. PubMed ID: 35587030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
    Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
    Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination.
    Werbrouck E; Spiessens C; Meuleman C; D'Hooghe T
    Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
    Wessel JA; Mol F; Danhof NA; Bensdorp AJ; Tjon-Kon Fat RI; Broekmans FJM; Hoek A; Mol BWJ; Mochtar MH; van Wely M;
    Hum Reprod; 2021 Feb; 36(3):817-825. PubMed ID: 33347597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis.
    Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH;
    Hum Reprod Open; 2020; 2020(1):hoz024. PubMed ID: 31934648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Bhattacharya S; Vale L; Templeton A
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.